1. New strategies for the development of lipid-lowering therapies to reduce cardiovascular risk. Issue 2 (28th November 2017) Authors: Graham, Ian; Shear, Chuck; De Graeff, Pieter; Boulton, Caroline; Catapano, Alberico L; Stough, Wendy Gattis; Carlsson, Stefan C; De Backer, Guy; Emmerich, Joseph; Greenfeder, Scott; Kim, Albert M; Lautsch, Dominik; Nguyen, Tu; Nissen, Steven E; Prasad, Krishna; Ray, Kausik K; Robinson, Jennifer G... Journal: European heart journal Issue: Volume 4:Issue 2(2018:Apr.) Page Start: 119 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. New prospects for PCSK9 inhibition?. (22nd March 2018) Authors: Landmesser, Ulf; Chapman, M John; Stock, Jane K; Amarenco, Pierre; Belch, Jill J F; Borén, Jan; Farnier, Michel; Ference, Brian A; Gielen, Stephan; Graham, Ian; Grobbee, Diederick E; Hovingh, G Kees; Lüscher, Thomas F; Piepoli, Massimo F; Ray, Kausik K; Stroes, Erik S; Wiklund, Olov; Windecker, S... Journal: European heart journal Issue: Volume 39:Number 27(2018) Page Start: 2600 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Quantifying atherogenic lipoproteins for lipid-lowering strategies: Consensus-based recommendations from EAS and EFLM. (February 2020) Authors: Nordestgaard, Børge G.; Langlois, Michel R.; Langsted, Anne; Chapman, M. John; Aakre, Kristin M.; Baum, Hannsjörg; Borén, Jan; Bruckert, Eric; Catapano, Alberico; Cobbaert, Christa; Collinson, Paul; Descamps, Olivier S.; Duff, Christopher J.; von Eckardstein, Arnold; Hammerer-Lercher, Angelika; K... Journal: Atherosclerosis Issue: Volume 294(2020) Page Start: 46 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Corrigendum to "2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk" [Atherosclerosis 290 (2019) 140–205]. (February 2020) Authors: Mach, Francois; Baigent, Colin; Catapano, Alberico L.; Koskinas, Konstantinos C.; Casula, Manuela; Badimon, Lina; Chapman, M. John; De Backer, Guy G.; Delgado, Victoria; Ference, Brian A.; Graham, Ian M.; Halliday, Alison; Landmesser, Ulf; Mihaylova, Borislava; Pedersen, Terje R.; Riccardi, Gabri... Journal: Atherosclerosis Issue: Volume 294(2020) Page Start: 80 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Pharmacological lipid lowering for prevention of cardiovascular disease in older adults. (January 2014) Authors: Wiklund, Olov; Pirazzi, Carlo; Romeo, Stefano Journal: Clinical practice Issue: Volume 11:Number 1(2014) Page Start: 49 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. PNPLA3 has retinyl-palmitate lipase activity in human hepatic stellate cells. (25th March 2014) Authors: Pirazzi, Carlo; Valenti, Luca; Motta, Benedetta Maria; Pingitore, Piero; Hedfalk, Kristina; Mancina, Rosellina Margherita; Burza, Maria Antonella; Indiveri, Cesare; Ferro, Yvelise; Montalcini, Tiziana; Maglio, Cristina; Dongiovanni, Paola; Fargion, Silvia; Rametta, Raffaela; Pujia, Arturo; Anders... Journal: Human molecular genetics Issue: Volume 23:Number 15(2014:Aug. 01) Page Start: 4077 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. In Memoriam: German Camejo (1936–2021). (January 2022) Authors: Wiklund, Olov; Bondjers, Göran Journal: Atherosclerosis Issue: Volume 341(2022) Page Start: 80 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. German Camejo (1936–2021). Issue 3 (24th February 2022) Authors: Wiklund, Olov; Bondjers, Göran Journal: Arteriosclerosis, thrombosis, and vascular biology Issue: Volume 42:Issue 3(2022) Page Start: 241 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS). (31st August 2019) Authors: Mach, François; Baigent, Colin; Catapano, Alberico L; Koskinas, Konstantinos C; Casula, Manuela; Badimon, Lina; Chapman, M John; De Backer, Guy G; Delgado, Victoria; Ference, Brian A; Graham, Ian M; Halliday, Alison; Landmesser, Ulf; Mihaylova, Borislava; Pedersen, Terje R; Riccardi, Gabriele; Ri... Journal: European heart journal Issue: Volume 41:Number 1(2020) Page Start: 111 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. European Society of Cardiology/European Atherosclerosis Society Task Force consensus statement on proprotein convertase subtilisin/kexin type 9 inhibitors: practical guidance for use in patients at very high cardiovascular risk. (27th October 2016) Authors: Landmesser, Ulf; John Chapman, M.; Farnier, Michel; Gencer, Baris; Gielen, Stephan; Hovingh, G. Kees; Lüscher, Thomas F.; Sinning, David; Tokgözoğlu, Lale; Wiklund, Olov; Zamorano, Jose Luis; Pinto, Fausto J.; Catapano, Alberico L. Journal: European heart journal Issue: Volume 38:Number 29(2017) Page Start: 2245 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗